Sánchez-Fructuoso Ana, Prats Sánchez Dolores, Marqués Vidas María, López De Novales Eduardo, Barrientos Guzmán Alberto
Nephrology Department Hospital, Clinico San Carlos, Madrid, Spain.
Nephrol Dial Transplant. 2004 Jun;19 Suppl 3:iii26-31. doi: 10.1093/ndt/gfh1011.
Several groups have demonstrated that non-heart beating donation is a viable source of organs for transplantation. However, the theoretically worse graft function and survival of the kidneys obtained from non-heart beating donors (NHBDs) is still a matter of debate that has led to consider them as marginal donors for kidney transplantation.
In this report, we compare the outcome and course of 83 kidney transplants from NHBDs with those corresponding to 3177 adult cadaveric heart beating donor (HBD) transplants performed over the same period in our country. Graft and patient survival were estimated by means of Kaplan-Meier analysis. In addition, groups were compared using Cox proportional regression.
The delayed graft function (DGF) rate was higher on NHBD transplants than in HBD kidneys (58.8 vs 28.9%, P<0.0001). However, in 1998, where the highest number of NHBD transplants was performed, graft function estimated by serum creatinine levels at 3 months and 1 year, was significantly better in the NHBD transplant group (1.42+/-0.45 vs 1.66+/-0.66 and 1.45+/-0.59 vs 1.62+/-0.64, respectively, P = 0.01 and 0.07). Graft survival at 2 years was 97%, 95% at 4 years and 84% at 6 years for NHBDs and 97, 90 and 84%, respectively, for HBDs. Interestingly, DGF was a risk factor for worse graft survival in HBDs but not on NHBDs.
We conclude that, in our study, both graft function and graft survival of NHBD kidney transplants are at least similar to those from HBD transplants. Therefore, NHBDs should be considered as a viable source of non-marginal kidneys for transplant.
多个研究小组已证实,非心脏跳动供体是可行的器官移植来源。然而,从非心脏跳动供体(NHBD)获取的肾脏,其理论上较差的移植肾功能和存活率仍是一个有争议的问题,这导致人们将他们视为肾脏移植的边缘供体。
在本报告中,我们比较了83例NHBD肾移植的结果及过程,并与同期在我国进行的3177例成年尸体心脏跳动供体(HBD)肾移植相对应的数据进行比较。采用Kaplan-Meier分析评估移植肾和患者的存活率。此外,使用Cox比例回归对各组进行比较。
NHBD肾移植的移植肾功能延迟(DGF)发生率高于HBD肾(58.8%对28.9%,P<0.0001)。然而,在1998年,NHBD肾移植数量最多,3个月和1年时通过血清肌酐水平评估的移植肾功能,NHBD移植组明显更好(分别为1.42±0.45对1.66±0.66以及1.45±0.59对1.62±0.64,P = 0.01和0.07)。NHBD肾移植2年时移植肾存活率为97%,4年时为95%,6年时为84%;HBD肾移植2年、4年和6年时分别为97%、90%和84%。有趣的是,DGF是HBD肾移植肾存活率降低的一个危险因素,但在NHBD肾移植中并非如此。
我们得出结论,在我们的研究中,NHBD肾移植的移植肾功能和移植肾存活率至少与HBD肾移植相似。因此,NHBD应被视为可行的非边缘性肾脏移植来源。